The 5th Annual Covered Entities’ 340B Summit will explore the latest developments in the 340B space with regards to drug pricing transparency, HRSA 340B audits and federal oversight activities. Attendees will also examine the impact of recent policy changes, consider trends in pharmacy contracting strategies, drug management practices, and strategies to maintain compliance and ensure program integrity.
Join us to:
- Discover how to ensure compliance and program integrity
- Develop audit preparation strategies
- Learn ways to resolve dispute findings between covered entities and drug manufacturers
- Minimize risks and maximize opportunities for financial savings